Book Value per Share: Adagene Inc. (ADAG)
Adagene risks are linked to early-stage testing and a dependence on external financing. The consolidated book value of the share demonstrates capital dynamics, where the value 1.34 describes the current level. Growth is supported by the SAFEbody platform for creating targeted oncology drugs and strong pricing power derived from the development of safe, demand-inelastic immunotherapy methods.
Adagene Inc - analytical breakdowns and key metrics (ADAG)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:adagene.com - ADAG
For Adagene (ADAG), which relies on external capital due to a lack of commercial products and early-stage development risks, equity dynamics are critical. The calculated book value per share digitizes the difference between all assets and liabilities, allowing investors to track the actual remaining net assets per share and promptly identify any deceleration in the fundamental growth trend.
Competitors of Adagene (ADAG)
Argenx - Book Value per Share|BNTX - Book Value per Share|Book Value per Share ABVX (Abivax Corp)|ADMA (admabiologics.com) - Book Value of One Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|ENGN - Book Value per Share|Book Value per Share RAPT Therapeutics, Inc.|Aerovate Therapeutics (JBIO) - Equity per Share|ACRS (Aclaris Therapeutics, Inc.) - Book Value per Share|Book Value per Share Kyverna Therapeutics Inc.|TLSA: Book Value per Share|Book Value of One Share Cabaletta Bio Inc (CABA)|VTYX: Book Value per Share|theratech.com - Net Asset Value per Share|Avalo Therapeutics (AVTX) - Net Assets per Single Share|ELDN - Equity per Share|Book Value per Share AGEN|Climb Bio, Inc (CLYM) - Net Asset Value per Share|ZURA (Zura Bio Limited) - Book Value per Share|Book Value per Share atyrpharma.com|Book Value per Share ImageneBio Inc IMA|Equity per Share shattucklabs.com (STTK)|Book Value per Share EQ (Equillium)|Book Value per Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX|ATRA: Book Value of One Share|Net Assets per Single Share inflarx.de (IFRX)|X4 Pharmaceuticals Inc. (XFOR) - Share Book Value|ACET - Book Value per Share|Accounting Value of a Share Celularity Corp|Book Value per Share INMB|Book Value per Share BRNS (barinthusbio.com)|Net Assets per Single Share Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. - Accounting Value of a Share|AKTX: Net Assets per Single Share|ENLV - Accounting Value per Share|QTTB: Book Value per Share|Book Value per Share geovax.com|EDSA - Accounting Value per Share|Accounting Value of a Share iBio Inc|CARM (Carisma Therapeutics) - Book Value per Share|Net Assets per Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. - Net Assets per Single Share|HCW Biologics, Inc. - Accounting Value per Share|APVO: Net Assets per Single Share|AIM ImmunoTech, Inc. (AIM) - Accounting Value per Share|ADTX: Accounting Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|Net Assets per Single Share XORTX Therapeutics Inc. (XRTX)|Equity per Share reshapelifesciences.com|Revelation Biosciences, Inc. - Book Value per Share|Net Asset Value per Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI (Scinai)|Book Value per Share CalciMedica Inc CALI|Affimed Therapeutics (AFMD) - Book Value per Share|ALLK - Equity per Share|HOOK: Book Value per Share|IGM Biosciences (IGMS) - Book Value per Share|iTeos - Book Value per Share|Book Value of One Share Ocean Biomedical Corp|TC Biopharm - Book Value per Share|Net Asset Value per Share THRD (thirdharmonicbio.com)